B. Riley Financial Cuts biote (NASDAQ:BTMD) Price Target to $2.00
B. Riley Financial decreased their price objective on shares of biote from $3.00 to $2.00 and set a "neutral" rating for the company in a report on Thursday...
MarketBeat·8d ago
More News
biote Q4 Earnings Call Highlights
biote (NASDAQ:BTMD) used its fourth-quarter and full-year 2025 earnings call to outline changes made over the past year to its commercial organization and operating model, while also detailing...
MarketBeat·9d ago
biote Corp. (BTMD) Q4 Earnings and Revenues Top Estimates
biote Corp. (BTMD) delivered earnings and revenue surprises of +20.00% and +1.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
biote (NASDAQ:BTMD - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.05 by $0.01. biote had a...
MarketBeat·9d ago
Biote Reports Fourth Quarter and Full Year 2025 Financial Results
Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners patients, today announced financial results for the...
Business Wire·9d ago
biote (BTMD) Expected to Announce Earnings on Wednesday
biote (NASDAQ:BTMD) will be releasing its Q4 2025 earnings after the market closes on Wednesday, March 11. (View Earnings Report at...
MarketBeat·17d ago
Universal Health Services (UHS) Lags Q4 Earnings Estimates
Universal Health Services (UHS) delivered earnings and revenue surprises of -0.63% and +0.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·23d ago
Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call
biote Corp. (Nasdaq: BTMD) (Biote or the Company), a leading innovator advancing the healthspan of patients lives by providing hormone replacement therapy and healthy aging solutions, today announced...
Business Wire·23d ago
biote (NASDAQ:BTMD) Stock Price Up 0.5% - Should You Buy?
biote (NASDAQ:BTMD) Shares Up 0.5% - Time to Buy...
OrganiGram (OGI) delivered earnings and revenue surprises of -100.00% and -14.83%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?